SOX9 and neoplasm: Likewise, within cases with venous invasion, the 5-year disease-free survival of patients with SOX9-positive tumours was 62% versus 41% of patients with SOX9-negative tumours (P = 0.02) (Figures 4(c) and 4(d)).